​Acting AG Davenport filed a multistate complaint with 42 states and territories against Novartis AG and its generic subsidiaries Sandoz AG and Sandoz Group AG. The complaint alleges a systemic campaign to conspire with other generic manufacturers to fix prices, allocate markets, and rig bids for 31 different generic drugs, thereby driving up the cost of prescription drugs for New Jerseyans.

The complaint alleges that the conspiracy increased prices affecting the health insurance market, taxpayer-funded health care programs like Medicare and Medicaid, and individuals who end up paying inflated prices for their prescription drugs. The complaint also asserts that Novartis took steps to fraudulently transfer and drain assets from Sandoz and spin off Sandoz to shield Novartis from liability in the three previously filed state antitrust complaints against the company.

“The rising cost of health care continues to be a major driver of our affordability crisis. That’s why I’m committed to holding prescription drug companies accountable when their conduct violates the law and increases costs for New Jerseyans. As Attorney General, I am committed to making life more affordable for New Jerseyans, and I will continue to fight to keep prescription drug prices down for all residents.” – Acting AG Davenport